Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Combining treatments is key to managing vitiligo effectively.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

A new system was created to classify skin changes in cancer patients based on their treatment.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

The treatment was effective for lupus nephritis with manageable side effects.

A woman experienced temporary hair loss after taking albendazole, which resolved on its own within 3 months.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Candida antigen is an effective and promising treatment for alopecia areata.

The scalp lotion helped increase hair thickness in cancer patients undergoing chemotherapy.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Ayurveda-based care improved quality of life for breast cancer patients without serious side effects.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

Oral dutasteride is a recommended first treatment for frontal fibrosing alopecia.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

34% of patients on hepatitis C treatment had reversible skin issues.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.